Abstract:Viral hepatitis, caused by its etiology, hepatitis virus, is a public health problem globally. Among all infections caused by hepatitis-associated viruses, hepatitis B virus (HBV) infection remains the most serious medical concern. HBV infection particularly affects people in East Asia and Africa, the Mediterranean region, and Eastern Europe, with a prevalence rate of > 2%. Currently, approximately 1 billion people worldwide are infected with HBV, and nearly 30% of them experience chronic infection. Chronic HBV infection can lead to chronic hepatitis B (CHB), liver cirrhosis, and hepatocellular carcinoma (HCC), resulting in the related death of approximately 1 million people annually. Although preventative vaccines and antiviral therapies are currently available, there is no cure for this infection. Clinical testing is not only the gateway for diagnosis of HBV infection, but also crucial for judging the timing of medication, evaluating the effect of antiviral therapy, and predicting the risk of relapse after drug withdrawal in the whole follow-up management of hepatitis B infected persons. With advances in detection technology, it is now possible to measure various viral components in the blood to assess the clinical status of HBV infection. Serum viral products of HBV infection, such as HBV DNA, HBV RNA, hepatitis B surface antigen, hepatitis B e-antigen, and hepatitis B core-related antigen, are non-invasive indicators that are critical for the rapid diagnosis and management of related diseases. Improving the sensitivity of monitoring of these products is essential, and the development of corresponding detection technologies is pivotal in achieving this goal. This review aims to offer valuable insights into CHB infection and references for its effective treatment. We provide a comprehensive and systematic overview of classical and novel methods for detecting HBV serum viral products and discusses their clinical applications, along with the latest research progress in this field.

Systematic Optimization of Universal Real-Time Hypersensitive Fast Detection Method for HBsAg in Serum Based on SERS

Determination of Low Level HBsAg in Serum by Microparticle Enzyme Immunoassay.

Detection technology and clinical applications of serum viral products of hepatitis B virus infection

Label Free Hepatitis B Detection Based on Serum Derivative Surface Enhanced Raman Spectroscopy Combined with Multivariate Analysis.

Detection of Serum Markers of Hepatitis B Virus and Its Application in Clinical Diagnosis

A Highly Sensitive Detection System based on Proximity-dependent Hybridization with Computer-aided Affinity Maturation of a scFv Antibody

Rapid Detection System for Hepatitis B Surface Antigen (hbsag) Based on Immunomagnetic Separation, Multi-Angle Dynamic Light Scattering and Support Vector Machine

Magnetic separation and enzymatic catalysis conjugated colorimetric immunosensor for Hepatitis B surface antigen detection

A sensitive and quantitative immunochromatographic assay for HBsAg based on novel red silica nanoparticles

Nano-immuno-conjugates inspired by hydrophilic perovskite fluorescent spheres and magnetic assisted for detection of hepatitis B surface antigen

Detection of Hepatitis B virus antigen from human blood: SERS immunoassay in a microfluidic system

Highly Sensitive Hepatitis B Virus Identification by Antibody-Aptamer Sandwich Enzyme-Linked Immunosorbent Assay

Improved Analytical Sensitivity of Lateral Flow Assay Using Sponge for HBV Nucleic Acid Detection

Detection of low level HBsAg and its clinical significance

CRISPR/Cas12-Based Ultra-Sensitive and Specific Point-of-Care Detection of HBV

Ultrasensitive detection of serum hepatitis B virus by coupling ultrafiltration DNA extraction with real-time PCR

A molecular detection method for HBV pgRNA without RNA extraction based on nucleic acid hybridization

Highly sensitive plasmonic biosensor for hepatitis B virus DNA based on the surface etching of the active helical gold nanorods

A Highly Sensitive Strategy for Low-Abundance Hepatitis B Virus Detection Via One-Step Nested Polymerase Chain Reaction, Chemiluminescence Technology and Magnetic Separation.

Re-recognizing Serological Change Patterns and Antiviral Therapy Opportunity of Patients with Acute Hepatitis B Through Highly Sensitive Detection Technology.

Biosensors for Hepatitis B Virus Detection